Related Experiment Videos
[Clinical variability of autosomal-dominant juvenile diabetes (MODY)]
Abstract:
Occurrence prior to the age of 25 years, dominant inheritance, metabolic control without insulin for more than two years and mild course without late complications are considered characteristic of maturity-onset diabetes of young people (MODY). Diabetes or glucose tolerance disturbance was observed in 30 members of a family in five successive generations. The course of the disease within the family was variable: even after disease for several decades no diabetes-specific late complications were seen in 20 diabetics, six, in contrast, had serious complications such as proliferative retinopathy, nephropathy and coma. The different clinical course is expression of the considerable variability of this genetically uniform metabolic disorder. Our observations demonstrate that vascular complications in MODY are less frequent than in type II diabetes, however are not excluded. Thus, also MODY diabetics require life-long careful metabolic surveillance.
Insights
Maturity-onset diabetes of young people (MODY) presents with variable clinical courses, even within genetically similar families. Careful metabolic monitoring is crucial for all MODY patients due to potential vascular complications.
Area of Science:
- Endocrinology
- Genetics
- Metabolic Disorders
Background:
- Maturity-onset diabetes of young people (MODY) is characterized by early onset, dominant inheritance, and insulin-independent control.
- Understanding the variability in MODY's clinical presentation and long-term outcomes is essential for effective patient management.
Observation:
- A five-generation family study identified 30 members with diabetes or glucose intolerance.
- The clinical course of MODY varied significantly within the family, with some individuals developing severe complications like retinopathy and nephropathy, while others remained free of diabetes-specific late complications for decades.
Findings:
- Despite a genetically uniform disorder, MODY exhibits considerable clinical variability.
- Vascular complications, though less frequent than in type II diabetes, can occur in MODY patients.
Implications:
- MODY patients require lifelong, diligent metabolic surveillance to detect and manage potential complications.
- Recognizing the variability in MODY is key to tailoring patient care and improving long-term prognoses.